An Aged Canid with Behavioral Deficits Exhibits Blood and Cerebrospinal Fluid Amyloid Beta Oligomers

被引:11
|
作者
Rusbridge, Clare [1 ,2 ]
Salguero, Francisco J. [1 ]
David, Monique Antoinette [3 ]
Faller, Kiterie M. E. [4 ]
Bras, Jose T. [5 ,6 ,7 ]
Guerreiro, Rita J. [5 ,6 ,7 ]
Richard-Londt, Angela C. [8 ,9 ]
Grainger, Duncan [1 ]
Head, Elizabeth [10 ]
Brandner, Sebastian G. P. [8 ,9 ]
Summers, Brian
Hardy, John
Tayebi, Mourad [1 ,3 ]
机构
[1] Univ Surrey, Fac Hlth & Med Sci, Dept Pathol & Infect Dis, Guildford, Surrey, England
[2] Fitzpatrick Referrals, Godalming, Surrey, England
[3] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia
[4] Univ Glasgow, Sch Vet Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland
[5] UCL, Inst Neurol, Dept Mol Neurosci, London, England
[6] Univ Aveiro, Dept Med Sci, Aveiro, Portugal
[7] Univ Aveiro, Inst Biomed iBiMED, Aveiro, Portugal
[8] UCL, Inst Neurol, Div Neuropathol, London, England
[9] UCL, Inst Neurol, Dept Neurodegenerat Dis, London, England
[10] Univ Kentucky, Sanders Brown Ctr Aging, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA
来源
关键词
canine cognitive dysfunction; Alzheimer; canine; A beta oligomers; neuropathology; aggregation; neurotoxicity; ALZHEIMERS-DISEASE; BRAIN; DOGS; ANTIBODIES; PROTEINS; PATHWAY; MODEL;
D O I
10.3389/fnagi.2018.00007
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Many of the molecular and pathological features associated with human Alzheimer disease (AD) are mirrored in the naturally occurring age-associated neuropathology in the canine species. In aged dogs with declining learned behavior and memory the severity of cognitive dysfunction parallels the progressive build up and location of A beta in the brain. The main aim of this work was to study the biological behavior of soluble oligomers isolated from an aged dog with cognitive dysfunction through investigating their interaction with a human cell line and synthetic A beta peptides. We report that soluble oligomers were specifically detected in the dog's blood and cerebrospinal fluid (CSF) via anti-oligomer-and anti-A beta specific binders. Importantly, our results reveal the potent neurotoxic effects of the dog's CSF on cell viability and the seeding efficiency of the CSF-borne soluble oligomers on the thermodynamic activity and the aggregation kinetics of synthetic human A beta. The value of further characterizing the naturally occurring Alzheimer-like neuropathology in dogs using genetic and molecular tools is discussed.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Alzheimers soluble amyloid beta and apolipoproteins of the cerebrospinal fluid: A mass spectrometry study.
    Koudinov, A
    Koudinova, N
    Berezov, T
    Beavis, R
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (10) : II - II
  • [42] Alzheimer’s disease risk variants show association with cerebrospinal fluid amyloid beta
    John S. K. Kauwe
    Jun Wang
    Kevin Mayo
    John C. Morris
    Anne M. Fagan
    David M. Holtzman
    Alison M. Goate
    neurogenetics, 2009, 10 : 13 - 17
  • [43] Abnormalities of tau-protein and beta-amyloid in brain ventricle cerebrospinal fluid
    Talab, Radomir
    Valis, Martin
    Rehak, Svatopluk
    Andrys, Ctirad
    Krejsek, Jan
    NEUROENDOCRINOLOGY LETTERS, 2009, 30 (05) : 647 - 651
  • [44] Assessment of amyloid beta protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease
    Southwick, PC
    Yamagata, SK
    Echols, CL
    Higson, GJ
    Neynaber, SA
    Parson, RE
    Munroe, WA
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 (01) : 259 - 265
  • [45] Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease
    Tamaoka, A
    Sawamura, N
    Fukushima, T
    Shoji, S
    Matsubara, E
    Shoji, M
    Hirai, S
    Furiya, Y
    Endoh, R
    Mori, H
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 148 (01) : 41 - 45
  • [46] SECRETED FORMS OF AMYLOID BETA-PROTEIN PRECURSOR IN CEREBROSPINAL-FLUID AND SERA
    HARIGAYA, Y
    SHOJI, M
    ISHIGURO, K
    KANAI, H
    YAMAGUCHI, H
    OKAMOTO, K
    HIRAI, S
    TAKATAMA, M
    NEUROBIOLOGY OF AGING, 1990, 11 (03) : 308 - 308
  • [47] Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta
    Kauwe, John S. K.
    Wang, Jun
    Mayo, Kevin
    Morris, John C.
    Fagan, Anne M.
    Holtzman, David M.
    Goate, Alison M.
    NEUROGENETICS, 2009, 10 (01) : 13 - 17
  • [48] Biomarkers in MSA and PSP:: Cerebrospinal fluid concentrations of axonal markers and beta-Amyloid
    Suessmuth, S. D.
    Brettschneider, J.
    Petzold, A.
    Kassubek, J.
    Landwehrmeyer, B.
    Ludolph, A. C.
    Tumani, H.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (03) : XVII - XVIII
  • [49] Sphingolipid Metabolism Correlates with Cerebrospinal Fluid Beta Amyloid Levels in Alzheimer's Disease
    Fonteh, Alfred N.
    Ormseth, Cora
    Chiang, Jiarong
    Cipolla, Matthew
    Arakaki, Xianghong
    Harrington, Michael G.
    PLOS ONE, 2015, 10 (05):
  • [50] Detection of glycerophospholipids and sphingolipids in urine and their correlation with cerebrospinal fluid beta-amyloid 42
    Fonteh, Alfred N.
    Cipolla, Matthew
    Chiang, Jiarong
    Castor, Katherine
    Harrington, Michael
    FASEB JOURNAL, 2016, 30